4.7 Article

Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 126, 期 -, 页码 384-407

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2016.11.029

关键词

-

资金

  1. Marie Curie FP7Reintegration-Grants within the 7th European Community Framework Programme
  2. project operated within the Foundation for Polish Science TEAM Programme
  3. EU European Regional Development Fund
  4. Polish National Centre of Science [Symphony-2-UM0-2014/12/W/NZ1/00457]
  5. National Centre of Science [UMO-2014/12/T/ST5/00684]
  6. European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program [POIG.02.01.00-12-023/08]
  7. NIH [1R01GM097082]
  8. Innovative Medicines Initiative [115489]
  9. Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University
  10. Leading National Research Centre (KNOW)
  11. Ministry of Science and Higher Education

向作者/读者索取更多资源

Using the computational pharmacophore-based ANCHOR.QUERY platform a new scaffold was discovered. Potent compounds evolved inhibiting the protein-protein interaction p53-MDM2. An extensive SAR study was performed based on our four-point pharmacophore model, yielding derivatives with affinity to MDM2 in the nanomolar range. Their binding affinity with MDM2 was evaluated using both fluorescence polarization (FP) assay and 2D-NMR-HSQC experiments. 2016 Published by Elsevier Masson SAS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据